Citigroup’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Sell |
78,537
-63,714
| -45% | -$1.5M | ﹤0.01% | 2098 |
|
|
2025
Q1 | $3.42M | Buy |
142,251
+24,767
| +21% | +$595K | ﹤0.01% | 1696 |
|
|
2024
Q4 | $4.97M | Buy |
117,484
+88,080
| +300% | +$3.72M | ﹤0.01% | 1417 |
|
|
2024
Q3 | $1.3M | Buy |
29,404
+8,122
| +38% | +$359K | ﹤0.01% | 2362 |
|
|
2024
Q2 | $770K | Sell |
21,282
-131,286
| -86% | -$4.75M | ﹤0.01% | 2417 |
|
|
2024
Q1 | $6.58M | Buy |
152,568
+82,263
| +117% | +$3.55M | ﹤0.01% | 1104 |
|
|
2023
Q4 | $1.08M | Buy |
70,305
+12,915
| +23% | +$199K | ﹤0.01% | 2094 |
|
|
2023
Q3 | $787K | Buy |
57,390
+47,322
| +470% | +$649K | ﹤0.01% | 2081 |
|
|
2023
Q2 | $162K | Buy |
+10,068
| New | +$162K | ﹤0.01% | 3333 |
|
|
2023
Q1 | – | Sell |
-467
| Closed | -$9.04K | – | 4951 |
|
|
2022
Q4 | $9.04K | Sell |
467
-783
| -63% | -$15.2K | ﹤0.01% | 4164 |
|
|
2022
Q3 | $27K | Sell |
1,250
-9,980
| -89% | -$216K | ﹤0.01% | 3918 |
|
|
2022
Q2 | $153K | Buy |
11,230
+335
| +3% | +$4.56K | ﹤0.01% | 3329 |
|
|
2022
Q1 | $256K | Buy |
10,895
+8,238
| +310% | +$194K | ﹤0.01% | 3257 |
|
|
2021
Q4 | $71K | Buy |
2,657
+1,847
| +228% | +$49.4K | ﹤0.01% | 4148 |
|
|
2021
Q3 | $14K | Buy |
+810
| New | +$14K | ﹤0.01% | 4624 |
|